Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / draft-uspi-psoriasis-rev3.docx
draft-uspi-psoriasis-rev3.docx
High · 0
Medium · 1
Standard · 0
CALDERWOOD & HARKNESS LLP 1700 K Street, N.W., Suite 800 Washington, D.C. 20006
Medium
⚑ Liability cap to check against exposure
CALDERWOOD & HARKNESS LLP 1700 K Street, N.W., Suite 800 Washington, D.C. 20006 PRIVILEGED & CONFIDENTIAL — ATTORNEY WORK PRODUCT DRAFT — NOT FOR SUBMISSION ANNOTATED DRAFT — PROPOSED PRESCRIBING INFORMATION VELONATIB® (velonatib hydrochloride) tablets, for oral use NDA No. 215-847 — sNDA (Psoriasis Indication) Revision 3 — October 15, 2022 Prepared by: Sean Morrissey & Christopher Aiken, Calderwood & Harkness LLP Re